Reported Oct 3, 2012 · Terminated
Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx…
Actavis
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Actavis · 575/577/579 Chipeta Way · Salt Lake City, UT · 84108-1222
Is this the product you have?
- Fentanyl Transdermal System, 100 mcg/h
- each transdermal system contains10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA
- Distributed byWatson, Pharma Inc
- Lot codes and dates
- Lot number 455040A (carton) 455040 (pouch)
- Amount recalled
- 98,088 cartons (5 pouches per carton)
Where it was sold
- Nationwide
Why it was recalled
Subpotent; some patches may not contain fentanyl gel
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Actavis recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.